van Hagen P Martin, Dalm Virgil A, Staal Frank, Hofland Leo J
Department of Immunology, Erasmus Medical School, Rotterdam, The Netherlands.
Mol Cell Endocrinol. 2008 May 14;286(1-2):141-7. doi: 10.1016/j.mce.2008.03.007. Epub 2008 Mar 27.
Cortistatin (CST) is a recently described neuropeptide that shares high homology with somatostatin (somatotropin release-inhibiting factor, SRIF) and binds with high affinity to all somatostatin (sst) receptor subtypes. CST is currently known to have a widespread distribution in many human organs including the immune system. The activities specific to CST may be partially attributable to its binding to the growth hormone secretagogue (GHS)-receptor (GHS-R) and the orphan G-protein-coupled receptor MrgX2. Human immune cells produce CST, whereas macrophage lineage and activated endothelium express sst2, and human lymphocytes express sst3. The human thymus expresses sst1, 2, 3, MrgX2 and almost all immune cells express GHS-R. Moreover, at this very moment promising research with CST in experimental animal models is being performed. On the basis of these promising results, studies aiming to further evaluate the possibilities of CST as a therapeutic agent in human immune-mediated inflammatory diseases are warranted.
促皮质素释放抑制因子(CST)是一种最近被描述的神经肽,它与生长抑素(促生长激素释放抑制因子,SRIF)具有高度同源性,并与所有生长抑素(sst)受体亚型具有高亲和力结合。目前已知CST在包括免疫系统在内的许多人体器官中广泛分布。CST的特定活性可能部分归因于其与生长激素促分泌素(GHS)受体(GHS-R)和孤儿G蛋白偶联受体MrgX2的结合。人类免疫细胞产生CST,而巨噬细胞谱系和活化内皮细胞表达sst2,人类淋巴细胞表达sst3。人类胸腺表达sst1、2、3、MrgX2,几乎所有免疫细胞都表达GHS-R。此外,目前正在实验动物模型中对CST进行有前景的研究。基于这些有前景的结果,有必要开展旨在进一步评估CST作为人类免疫介导的炎症性疾病治疗药物可能性的研究。